Barclays analyst Andrew Mok raised targets across five managed care names on Monday. The sweep covers UnitedHealth Group, Humana, Elevance Health, CVS Health, and Centene.
The most striking call was on Humana. Mok lifted his target to $344, up sharply from $180. That's a 91% jump in his price target. The stock carries short interest of 5.6% of free float.
Centene's target moved from $63 to $75 — a 19% increase. Mok kept a Buy rating there. Elevance saw its target rise to $480 from $408, also with a Buy.
UnitedHealth's target climbed to $429 from $373. The stock has been under pressure after a string of negative headlines. Short interest stands at just 2.2% of free float, suggesting bears haven't piled in heavily.
Also at Barclays, energy analyst Betty Jiang raised her target on Exxon Mobil to $182 from $163 and bumped EOG Resources to $153 from $140.
In other moves, Prologis and Aon both saw modest consensus target upgrades. Danaher bucked the trend with a small target cut, slipping to $246 from $248.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
